Innovation Pharmaceuticals Inc (IPIX)

[govorchin]

the K at DF was designed for both safety AND efficacy. efficacy was shown at very low doses as per R&R presentation 2013. more efficacy was shown when tumor stabilized at 75 .

dr menon is supposed to have said ( i personally believe this is true) that the trial is going the same way as the mouse pre clinical. we all know what that means but who is he compared to the posters on this board who hint this is maybe a maybe.

i remind people BK says he has an impeccable source that dr j spent his time explaining what(i think B don;t you?) to industry representatives. he is said to have consulted with leo during the presentation by phone. therefore we are told sorta that these representatives could be nobody. LOL (my editorial comment).

my own thinking is ( i say again mY OWN THINKING) that BK knows who these interested parties are. in following him for 4 years i do not find that he either `exaggerates or is reckless. i am expecting good news of a deal before june.

gov